Sign In
Buy INCR
$1.04
+0.0100 (+0.97%)
At Close: Jun 03, 2026
InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript
06:56pm, Tuesday, 04'th Apr 2023
InterCure Ltd. (NASDAQ:INCR ) Q4 2022 Earnings Conference Call April 4, 2023 4:30 PM ET Company Participants Alexander Rabinovitch - CEO & Director Amos Cohen - CFO Conference Call Participants Vivien
InterCure Reschedules 2022 Full Year Results Conference Call
03:27pm, Monday, 03'rd Apr 2023
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today th
InterCure: Why The Company Is Grossly Undervalued By Wall Street
12:22pm, Friday, 20'th Jan 2023
InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 12
Cannabis Is A Long-Term Play (Podcast Transcript)
06:30am, Monday, 09'th Jan 2023
Negative conditions are crashing down all around investors. Make sure companies in your portfolio will survive.
Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth
11:42pm, Tuesday, 08'th Nov 2022
Legal cannabis around the world is just beginning but will surpass that of North America. Europe is one of the largest growth markets for companies in global cannabis.
InterCure: Highlighting A Profitable Israeli Cannabis Operator
12:11pm, Tuesday, 25'th Oct 2022
InterCure is the leading cannabis operator in Israel. Israel is currently a medical market, with recreational legalization expected to occur over the coming years.
InterCure: A Leader In Global Cannabis
05:25pm, Tuesday, 06'th Sep 2022
The global cannabis market will eventually be far bigger than North America. InterCure is a leading company in global pharmaceutical cannabis.
InterCure Ltd (INCR) CEO Alexander Rabinovitch on Q2 2022 Results - Earnings Call Transcript
02:11pm, Tuesday, 16'th Aug 2022
InterCure Ltd (NASDAQ:INCR ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Adam Haliva - Communications Officer Alexander Rabinovitch - CEO & Director Amos Cohen - C
